Running out of bullets: The challenging management of acute hepatitis and SARS-COV-2 from the SMatteo COvid19 Registry (SMACORE).
Liver Int
; 40(11): 2655-2659, 2020 11.
Article
in English
| MEDLINE | ID: covidwho-654155
ABSTRACT
Liver impairment is frequent in patients with novel coronavirus disease (COVID-19) and direct viral tropism for the liver has been proven. Since several of the currently administered drugs against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are possibly hepatotoxic, the management of patients with COVID-19 and liver failure is still an almost unexplored field. Taking this challenging case of acute HBV with persistent hyperbilirubinemia and SARS-COV-2 infection with respiratory distress as a starting point, we here loop through this condition. Where the available therapeutic options are scarce, we here propose hemoperfusion (HP) as an attractive alternative to both delay any late-stage progression of hyper inflammation process in COVID-19 and remove the toxins involved in acute liver failure.
Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Registries
/
COVID-19
/
Hepatitis B
Type of study:
Case report
Topics:
Long Covid
Limits:
Humans
/
Male
/
Middle aged
Language:
English
Journal:
Liver Int
Journal subject:
Gastroenterology
Year:
2020
Document Type:
Article
Affiliation country:
Liv.14609
Similar
MEDLINE
...
LILACS
LIS